| Literature DB >> 25547684 |
Xiaowei Xu1, Sulin Ren, Xiaoxiao Chen, Jun Ge, Zhenxing Xu, Hongying Huang, Honglin Sun, Yue Gu, Tong Zhou, Jianqiang Li, Hanmei Xu.
Abstract
Despite the long availability of a traditional prophylactic vaccine containing the HBV surface antigen (HBsAg) and aluminum adjuvant, nearly 10% of the population remains unable to generate an effective immune response. Previous studies have indicated that hepatitis B virus (HBV) PreS2-S is abundant in T/B cell epitopes, which induces a stronger immune response than HBsAg, particularly in terms of cytotoxic T lymphocyte (CTL) reaction. In the current study, the HBV PreS2-S gene encoding an extra 26 amino acids (PreS2 C-terminus) located at the N-terminus of HBsAg was cloned into the pVCH1300 expression vector. PreS2-S expressed in the methylotrophic yeast, Hansenula polymorpha, was produced at a yield of up to 250 mg/L. Subsequent purification steps involved hydrophobic adsorption to colloidal silica, ion-exchange chromatography and density ultracentrifugation. The final product was obtained with a total yield of ∼ 15% and purity of ∼ 99%. In keeping with previous studies, ∼ 22 nm viruslike particles were detected using electron microscopy. The generated PreS2-S antigen will be further studied for efficacy and safty in animals.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25547684 PMCID: PMC8206452 DOI: 10.1007/s12250-014-3508-9
Source DB: PubMed Journal: Virol Sin ISSN: 1995-820X Impact factor: 4.327